ImmunoGen surges after cancer drug study hits a ‘home run’ – Reuters

by

  1. ImmunoGen surges after cancer drug study hits a ‘home run’ Reuters
  2. ELAHERE® Demonstrates Overall Survival Benefit in the Phase 3 MIRASOL Trial in Patients with FRα-Positive Platinum-Resistant Ovarian Cancer Yahoo Finance
  3. ImmunoGen Touts Additional Positive Data From Ovarian Cancer Drug, Seeks Expanded Use Approval, Stock Soa Benzinga
  4. Why Is ImmunoGen (IMGN) Stock Up 125% Today? InvestorPlace
  5. ImmunoGen Touts Additional Positive Data From Ovarian Cancer Drug, Seeks Expanded Use Approval, Stock Soars Yahoo Finance
  6. View Full Coverage on Google News

Read original article here

Leave a Comment